STANISLAS (Suivi Temporaire Annuel Non Invasif de la Santé des Lorrains Assurés Sociaux) - STANISLAS cohort

Head :
Visvikis-Siest Sophie, UMR INSERM U1122; IGE - PCV

Stathopoulou Maria

Last update : 10/25/2017 | Version : 6 | ID : 60111

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name STANISLAS cohort
Sign or acronym STANISLAS (Suivi Temporaire Annuel Non Invasif de la Santé des Lorrains Assurés Sociaux)
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL n°901090 (27/10/2003)
General Aspects
Medical area Biology
Cardiology
General practice
Pathology (details) Environnement
Health determinants Genetic
Keywords family determinants, indicators, cardiovascular risk, cross-sectional, longitudinal, genetic, environment
Scientific investigator(s) (Contact)
Name of the director Visvikis-Siest
Surname Sophie
Address 30 rue Lionnois - 54000 NANCY
Phone +33 (0)6 07 60 25 69
Email Sophie.Visvikis-Siest@inserm.fr
Unit UMR INSERM U1122; IGE - PCV
Organization INSERM - Institut National de la Santé et de la Recherche
Name of the director Stathopoulou
Surname Maria
Phone + 33 3 (0)83 68 21 66
Email maria.stathopoulou@inserm.fr
Organization INSERM
Collaborations
Participation in projects, networks and consortia Yes
Details Consortia VEGF, MAGIC, CHARGE, NCD Risk Factor Collaboration
Funding
Funding status Mixed
Details Inserm, Université Henri Poincaré (Actuellement Université de Lorraine), Contrat Européen Biomed 2, Région Lorraine, Communauté urbaine du grand Nancy, CNAMTS, ABBOTT, BAYER PHARMA, BECKMAN COULTER, BIOMERIEUX, DADE-BEHRING, DAIICHI, JOHNSON AND JOHNSON (ORTHO-CLINICAL DIAGNOSTICS), KELLOGS, LA PREVIADE, MERCK, RANDOX, ROCHE, SEBIA.
Governance of the database
Sponsor(s) or organisation(s) responsible UMR INSERM U1122, IGE-PCV (Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire)
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Longitudinal study (except cohorts)
Database recruitment is carried out by an intermediary A population file
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Prospective Inclusions ended on: 01/01/1995
Database objective
Main objective study the family determinants (genetic and environmental) of cardiovascular risk indicators and/or factors by using the model of the nuclear family. The 2 aspects, cross-sectional and longitudinal, are broached through specific designs.
Inclusion criteria Nuclear families, at least 2 children/family, of French origin over 3 generations
Population type
Age Childhood (6 to 13 years)
Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Population covered General population
Pathology
Gender Male
Woman
Geography area Local
French regions covered by the database Alsace Champagne-Ardenne Lorraine
Detail of the geography area MEURTHE ET MOSELLE SUD, VOSGES
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 01/1993
Date of last collection (YYYY or MM/YYYY) 06/2004
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 4295 patients / bilan 1 (1006 familles/families)2952 patients / bilan 2 (756 familles/families)359 patients / bilan 3 (99 familles/families)
Data
Database activity Current data collection
Type of data collected Clinical data
Declarative data
Paraclinical data
Biological data
Clinical data (detail) Medical registration
Details of collected clinical data Clinical examination upon inclusion and during follow-up every 5 years.Information gathered during the clinical examination: physical measurements (weight, height, waist size and hip size), blood pressure and heart rate.Electrocardiogram with a Cardionics devicePuberty development in 9 to 18 year olds from the assessment of pubic hair, development of external genitals in boys and breast development and whether or not periods have started in girls.Measurement of the arterial tunica media-intima thickness and arterial rigidity (in a small number of families).Measurement of the body fat percentage and lean body mass using diagnostic scales (in a small number of families).
Declarative data (detail) Paper self-questionnaire
Details of collected declarative data Clinical examination upon inclusion and during follow-up every 5 years.Information gathered during the clinical examination: physical measurements (weight, height, waist size and hip size), blood pressure and heart rate.Electrocardiogram with a Cardionics devicePuberty development in 9 to 18 year olds from the assessment of pubic hair, development of external genitals in boys and breast development and whether or not periods have started in girls.Measurement of the arterial tunica media-intima thickness and arterial rigidity (in a small number of families).Measurement of the body fat percentage and lean body mass using diagnostic scales (in a small number of families).
Paraclinical data (detail) Height, weight, waist/hip measurement
Biological data (detail) total blood, serum, EDTA plasma, citrate plasma, heparin plasma, urine, PAXgene
Presence of a biobank Yes
Contents of biobank DNA
DNAc/RNAm
Others
Details of biobank content Serum bank, plasma bank, DNA bank, PBMCS FOR RNA, PAXGENE (RNA) PBMCS protein extracts, urines.
Health parameters studied Health event/morbidity
Others
Other (detail) cardiovascular diseases
Procedures
Data collection method Self-questionnaire: entry from a paper questionnaire with double entry Interviews: entry from a paper questionnaire with double entry
Quality procedure(s) used Management of missing data: according to the missing information, either exclusion of the subject or generation of variables
Participant monitoring Yes
Links to administrative sources Yes
Linked administrative sources (detail) Preventive Medicine Center, CHU Nancy
Promotion and access
Promotion
Link to the document Publications cohorte STANISLAS version 5-03-2015 - docx.docx
Link to the document http://tinyurl.com/Pubmed-STANISLAS
Link to the document http://tinyurl.com/Hal-STANISLAS
Access
Terms of data access (charter for data provision, format of data, availability delay) Cohort journal
Possible use of data by academic teams
Possible use of data by manufacturers
Involvement in a cohort network: BIOBANKING AND BIOMOLECULAR RESOURCES INFRASTRUCTURES (BBMRI) 7th FP
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05